Dendritic Cell Based Therapy of Metastatic Breast Cancer
NCT00197925
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
40
Enrollment
OTHER
Sponsor class
Stopped
all patients recruited
Conditions
Metastatic Breast Cancer
Interventions
BIOLOGICAL:
Onco-peptide loaded autologous dendritic cells
Sponsor
Herlev Hospital